Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast effect on bone metabolism and endothelial function in COPD
NCT01745848Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Feb 2013
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of roflumilast in chronic obstructive pulmonary disease (COPD), sponsored by University of Pittsburgh. Started Feb 2013; status: completed.
02
Drugs
roflumilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01745848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01745848.